Skip to main content

US ClosedU.S. Closed

AIDX: 20/20 Biolabs Inc. Stock Analysis | finqOS

Healthcare · Medical - Care Facilities

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services.

52W Range

0thpctl

Volume

0.11×avg

Market Cap

4.66MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

20/20 Biolabs Inc.

AIDXNASDAQ·USD·Closed

20/20 Biolabs Inc.

AIDXNASDAQ·USD·Closed

$0.38

−7.07%

$0.38

−$0.03 (7.07%)

52W Range

0thpctl

Volume

0.11×avg

Mkt Cap

4.66MUSD

P/E

-0.5TTM

Div Yield

–ann